RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Long-acting injections for women’s HIV prevention in Sub-Saharan Africa
What end-users think
Van Der Straten, A., Minnis, A. M., Agot, K., & Ahmed, K. (2021). Long-acting injections for women’s HIV prevention in Sub-Saharan Africa: What end-users think. RTI International.
Preference for injections underscored women’s desire for a long-acting delivery form that affords discreetness, ease of administration, and a low level of burden in their lives.
Healthcare providers emphasized the need to receive product-specific training so they are prepared to offer the most accurate information.
Women and healthcare providers expressed an overwhelming preference for MPTs, rather than single indication products (contraceptive or HIV prevention indication).
